Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Sunbelt Rentals Appoints Ekta Singh-Bushell to Board of Directors (Business Wire) +++ TTEC Aktie +3,55%

News zum Sektor Gesundheit aus Belgien

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 101 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1559 Aktien zum Sektor Gesundheit bekannt.
 
13.07.26 - 22:03
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi (GlobeNewswire EN)
 
Mechelen, Belgium; July 13, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA, Dr. Paulo Fontoura has tendered his resignation from the Board of Directors....
13.07.26 - 06:30
ANTENGENE-B Receives USD60 million Upfront Payment from UCB (AAStocks)
 
ANTENGENE-B (06996.HK) announced that, under the global exclusive licensing agreement reached with UCB for the CD19/CD3 bispecific T-cell engager (TCE) antibody ATG-201, it has received the first upfront payment of USD60 million from the company. The company expects the payment to further strengthen the group's cash position, pr......
13.07.26 - 06:03
Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB (PR Newswire)
 
SHANGHAI and HONG KONG, July 13, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for......
09.07.26 - 16:33
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight (PR Newswire)
 
Companies like Biogen and Royalty Pharma (Litifilimab), Biogen and UCB (Dapirolizumab pegol), Idorsia Pharmaceuticals and Viatris (Cenerimod), Novartis (Ianalumab, YTB3231), Kyowa Kirin (KK-4277), and others are advancing late, mid, and early-stage drugs, showing promise in the systemic......
08.07.26 - 18:01
OXURION : Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
08.07.26 - 15:06
UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S. (PR Newswire)
 
ATLANTA, July 8, 2026 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the recipients of its annual UCB Myasthenia Gravis Scholarship,™ awarding 15 scholarships to individuals in the United States who are living with myasthenia gravis (MG) or supporting a loved one......
07.07.26 - 22:24
Nyxoah reports Q2 2026 preliminary revenue of €7.7M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.07.26 - 22:09
Nyxoah Announces Preliminary Results for the Second Quarter of 2026 (GlobeNewswire EN)
 
Nyxoah Announces Preliminary Results for the Second Quarter of 2026...
06.07.26 - 18:30
OXURION : Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
02.07.26 - 22:24
Mdxhealth receives Nasdaq non-compliance notice after $1 bid price breach (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.07.26 - 22:03
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire EN)
 
IRVINE, California – July 2, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated June 30, 2026, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure upon the receipt of a deficiency notification....
30.06.26 - 22:03
Northampton Capital Partners, Olympus Power Form JV and Reach Agreement to Acquire New England, New York Generating Assets (Business Wire)
 
NEW YORK--(BUSINESS WIRE)--Northampton Capital Partners LLC (“Northampton”), an alternative asset management firm focused on infrastructure investments in the middle market targeting the energy, digital, and other critical infrastructure sectors, announced today that it has formed Winslow Power (“Winslow”) in partnership with Olympus Power, LLC (“Olympus”). Winslow has agreed to acquire three conventional power plants with a combined capacity of 752 MW from a subsidiary of Vistra Corp. Winslow's acquisition involves three assets, including the 541-MW Casco Bay combined cycle facility in Veazie, Maine, Beaver Falls, a 108-MW dual fuel combustion turbine in Croghan, NY, and Syracuse, a 103-MW dual fuel combustion turbine in Solvay, NY. The acquisition is subject to customary regulatory approvals and is expected to close later this year. Andrew Kapp, Founding Partner at Northampton Capital Partners, said, “Northampton is thrilled to partner with Olympus on what we believe is a long-term opport...
30.06.26 - 15:15
Bewertung, Chart und Story stimmig: AKTIONÄR-Hot-Stock vor dem nächsten Kursschub (Der Aktionaer)
 
Zahlreiche Medizintechnik-Aktien fristen im Schatten der großen Tech-Trends Halbleiter, KI und Co derzeit ein Schattendasein. Doch darin bestehen enorme Chancen für Anleger. So auch bei Ion Beam Applications. Die Aktie des belgischen Protonentherapie-Spezialisten lief viele Monate lethargisch seitwärts....
30.06.26 - 07:03
The National Proton Therapy Center of Portugal will be equipped with two IBA Proteus®ONE solutions (GlobeNewswire EN)
 
Louvain-La-Neuve, Belgium, June 30, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, announces today the entering into effect of a contract with Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto), for the installation of two Proteus®ONE1 compact proton therapy solutions at the IPO-Porto facilities in Porto, Portugal. The two Proteus®ONE systems will be the first proton therapy systems in the country and will serve as the National Proton Therapy Center of Portugal....
29.06.26 - 22:03
Lakefront Receives Transparency Notification from Madison Avenue Partners (GlobeNewswire EN)
 
Mechelen, Belgium; June 29, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Madison Avenue Partners....
26.06.26 - 18:01
OXURION : Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
25.06.26 - 07:03
IBA to install the first proton therapy center in Brazil in Rio de Janeiro (GlobeNewswire EN)
 
Louvain-La-Neuve, Belgium, June 25, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract with the Fundação Severino Sombra (FUSVE), a non-profit philanthropic healthcare and educational institution responsible for the University of Vassouras and Hospital Mário Kroeff, for the purchase of a Proteus®ONE1 system....
24.06.26 - 18:01
OXURION : Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
23.06.26 - 22:09
Nyxoah to Host Investor Day in New York on July 8, 2026 (GlobeNewswire EN)
 
Nyxoah to Host Investor Day in New York on July 8, 2026...
19.06.26 - 15:48
OXURION : Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Hafen ist ein reizvoller Aufenthalt für eine im Lebenskampf erschöpfte Seele. - Charles Baudelaire
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!